SANGAMO THERAPEUTICS INC's ticker is and the CUSIP is 800677906. A total of 3 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,247,000 | +43.3% | 878 | +91.7% | 0.19% | +271.2% |
| Q1 2018 | $870,000 | -91.2% | 458 | -92.4% | 0.05% | -94.2% |
| Q4 2017 | $9,906,000 | +65.8% | 6,040 | +51.6% | 0.90% | +130.7% |
| Q3 2017 | $5,976,000 | +74.5% | 3,984 | +2.4% | 0.39% | +74.6% |
| Q2 2017 | $3,425,000 | +88.6% | 3,892 | +11.4% | 0.22% | +128.6% |
| Q1 2017 | $1,816,000 | -3.6% | 3,493 | -43.5% | 0.10% | -10.9% |
| Q4 2016 | $1,884,000 | -27.5% | 6,177 | +10.1% | 0.11% | +13.4% |
| Q3 2016 | $2,598,000 | +2.0% | 5,611 | +27.5% | 0.10% | -27.1% |
| Q2 2016 | $2,548,000 | +40.2% | 4,400 | +46.4% | 0.13% | +46.2% |
| Q1 2016 | $1,818,000 | +62.6% | 3,005 | +145.3% | 0.09% | +49.2% |
| Q4 2015 | $1,118,000 | +824.0% | 1,225 | +469.8% | 0.06% | +1120.0% |
| Q3 2015 | $121,000 | -98.8% | 215 | -97.6% | 0.01% | -98.6% |
| Q2 2015 | $10,115,000 | -31.3% | 9,121 | -2.8% | 0.37% | -39.8% |
| Q1 2015 | $14,714,000 | -4.9% | 9,384 | -7.7% | 0.61% | +25.4% |
| Q4 2014 | $15,466,000 | +43.2% | 10,168 | +1.6% | 0.49% | +17.8% |
| Q3 2014 | $10,798,000 | -29.4% | 10,012 | 0.0% | 0.42% | -36.6% |
| Q2 2014 | $15,288,000 | -15.5% | 10,012 | +0.0% | 0.66% | -35.5% |
| Q1 2014 | $18,098,000 | – | 10,010 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 5,611 | $2,598,000 | 0.10% |
| GROUP ONE TRADING, L.P. | 138,200 | $640,000 | 0.01% |
| SIMPLEX TRADING, LLC | 821 | $47,000 | 0.00% |